Matches in Nanopublications for { ?s ?p "[A potential treatment strategy for SMA is to upregulate the amount of SMN protein originating from the highly homologous SMN2 gene, compensating in part for the absence of the functional SMN1 gene.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 13 of
13
with 100 items per page.
- NP705607.RAWFH4BYDFq8qnf1uxolJEeFV0L9IfuA5yReSPrLBJ_wA130_assertion description "[A potential treatment strategy for SMA is to upregulate the amount of SMN protein originating from the highly homologous SMN2 gene, compensating in part for the absence of the functional SMN1 gene.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP705607.RAWFH4BYDFq8qnf1uxolJEeFV0L9IfuA5yReSPrLBJ_wA130_provenance.
- assertion description "[A potential treatment strategy for SMA is to upregulate the amount of SMN protein originating from the highly homologous SMN2 gene, compensating in part for the absence of the functional SMN1 gene.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[A potential treatment strategy for SMA is to upregulate the amount of SMN protein originating from the highly homologous SMN2 gene, compensating in part for the absence of the functional SMN1 gene.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[A potential treatment strategy for SMA is to upregulate the amount of SMN protein originating from the highly homologous SMN2 gene, compensating in part for the absence of the functional SMN1 gene.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[A potential treatment strategy for SMA is to upregulate the amount of SMN protein originating from the highly homologous SMN2 gene, compensating in part for the absence of the functional SMN1 gene.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[A potential treatment strategy for SMA is to upregulate the amount of SMN protein originating from the highly homologous SMN2 gene, compensating in part for the absence of the functional SMN1 gene.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP1076071.RAXgvGpgwWSh6VQVX9bNOa6jzTNI_GLWap9rVO8frGugU130_assertion description "[A potential treatment strategy for SMA is to upregulate the amount of SMN protein originating from the highly homologous SMN2 gene, compensating in part for the absence of the functional SMN1 gene.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1076071.RAXgvGpgwWSh6VQVX9bNOa6jzTNI_GLWap9rVO8frGugU130_provenance.
- NP531742.RAFTI44gOKBKI6zvIareWiYVkAy2LerGCo1QdSex-kEe4130_assertion description "[A potential treatment strategy for SMA is to upregulate the amount of SMN protein originating from the highly homologous SMN2 gene, compensating in part for the absence of the functional SMN1 gene.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP531742.RAFTI44gOKBKI6zvIareWiYVkAy2LerGCo1QdSex-kEe4130_provenance.
- NP703469.RALHJpR9Z8stmp9TqikV8jT6Ze7RONKsEAYzkXQCazgmA130_assertion description "[A potential treatment strategy for SMA is to upregulate the amount of SMN protein originating from the highly homologous SMN2 gene, compensating in part for the absence of the functional SMN1 gene.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP703469.RALHJpR9Z8stmp9TqikV8jT6Ze7RONKsEAYzkXQCazgmA130_provenance.
- NP1076074.RAOHY8xWH7z73YsuHt-WhiXrPeJuPetXfDolrPCoGIRT0130_assertion description "[A potential treatment strategy for SMA is to upregulate the amount of SMN protein originating from the highly homologous SMN2 gene, compensating in part for the absence of the functional SMN1 gene.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1076074.RAOHY8xWH7z73YsuHt-WhiXrPeJuPetXfDolrPCoGIRT0130_provenance.
- NP703791.RAzhReRcdEPCyAzURC1t6R-j1yjmjJjQkKfDrcm_2E6sg130_assertion description "[A potential treatment strategy for SMA is to upregulate the amount of SMN protein originating from the highly homologous SMN2 gene, compensating in part for the absence of the functional SMN1 gene.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP703791.RAzhReRcdEPCyAzURC1t6R-j1yjmjJjQkKfDrcm_2E6sg130_provenance.
- NP1076070.RA5PQpJrrEjd9pGLUr315oz2sHWsn1jIWKX7Qk_Q3iwV0130_assertion description "[A potential treatment strategy for SMA is to upregulate the amount of SMN protein originating from the highly homologous SMN2 gene, compensating in part for the absence of the functional SMN1 gene.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1076070.RA5PQpJrrEjd9pGLUr315oz2sHWsn1jIWKX7Qk_Q3iwV0130_provenance.
- NP1076073.RA6R4ylo2jFsVfl3sqeqZuh3047tnfzkXOEm-CTPfC3xA130_assertion description "[A potential treatment strategy for SMA is to upregulate the amount of SMN protein originating from the highly homologous SMN2 gene, compensating in part for the absence of the functional SMN1 gene.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1076073.RA6R4ylo2jFsVfl3sqeqZuh3047tnfzkXOEm-CTPfC3xA130_provenance.